J 2015

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

FELICIANI, C.; P. JOLY; M.F. JONKMAN; G. ZAMBRUNO; D. ZILLIKENS et al.

Základní údaje

Originální název

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

Autoři

FELICIANI, C.; P. JOLY; M.F. JONKMAN; G. ZAMBRUNO; D. ZILLIKENS; D. IOANNIDES; C. KOWALEWSKI; Hana JEDLIČKOVÁ; S. KARPATI; B. MARINOVIC; D. MIMOUNI; S. UZUN; S. YAYLI; M. HERTL a L. BORRADORI

Vydání

British Journal of Dermatology, Hoboken, Wiley-Blackwell, 2015, 0007-0963

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30000 3. Medical and Health Sciences

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 4.317

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/15:00083985

Organizační jednotka

Lékařská fakulta

EID Scopus

Klíčová slova anglicky

LINKED-IMMUNOSORBENT-ASSAY; INDIRECT IMMUNOFLUORESCENCE; TOPICAL CORTICOSTEROIDS; MYCOPHENOLATE-MOFETIL; PLASMA-EXCHANGE; DIAGNOSIS; DISEASES; MULTICENTER; AZATHIOPRINE; ACQUISITA

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 24. 9. 2015 16:18, Soňa Böhmová

Anotace

V originále

Bullous pemphigoid is the most common autoimmune subepidermal blistering disease of the skin and mucous membranes. This disease typically affects the elderly and presents with itch and localized or generalized bullous lesions. In up to 20% of affected patients, bullae may be completely absent, and only excoriations, prurigo-like lesions, eczematous lesions, urticated lesions and/or infiltrated plaques are observed. The disease is significantly associated with neurological disorders. The morbidity of bullous pemphigoid and its impact on quality of life are significant. So far, a limited number of national treatment guidelines have been proposed, but no common European consensus has emerged. Our consensus for the treatment of bullous pemphigoid has been developed under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations.